Coagulation abnormality as a complication of L-asparaginase therapy in childhood lymphoblastic leukemia
Background Bleeding, one of the most common symptoms of acute leukemia in untreated patients, is mostly due to thrombocy- topenia as a result of myeloinvasion by leukemic cells. Neverthe- less, a further contributory factor for the additional hemorrhagic complication during intensive chemotherapy is...
Saved in:
Main Authors: | Djajadiman Gatot (Author), Keumala Pringgardini (Author), Rulina Suradi (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Pediatric Society Publishing House,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
by: Luke Maese, et al.
Published: (2022) -
Treatment of childhood acute lymphoblastic leukemia in Jakarta: Result of modified Indonesian National Protocol 94
by: Djajadiman Gatot, et al.
Published: (2016) -
Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase
by: Patel Zeeshan Jameel, et al.
Published: (2020) -
Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance
by: Shih-Hsiang Chen
Published: (2015) -
Coagulation profile during induction chemotherapy in childhood acute lymphoblastic leukemia
by: Shivali Sehgal, et al.
Published: (2017)